The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

The sabotage of cellular messaging, triggered by the formation of chronic stress granules in the brain, may be a key factor ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

The project specifically focused on the hippocampus, a region of the brain that's not only crucial for memory but also ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test ... many elderly people who have amyloid-beta plaques in their brains will never go on ...

Jan. 15, 2025 — Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...